Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer
Go back to Tessera Therapeutics Appoints Joseph Romanelli as President and Chief Executive Officer| Merck & Co. (NYSE: MRK) | Delayed: 148.78 +0.80 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.98 | 52 Week High | $65.46 | |||
| Open | $148.06 | 52 Week Low | $47.97 | |||
| Day High | $149.98 | P/E | 101.21 | |||
| Day Low | $147.48 | EPS | $1.47 | |||
| Volume | 8,290,254 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 788.04 -7.98 (1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $796.02 | 52 Week High | $592.36 | |||
| Open | $803.87 | 52 Week Low | $325.35 | |||
| Day High | $803.87 | P/E | 206.83 | |||
| Day Low | $784.13 | EPS | $3.81 | |||
| Volume | 592,144 | |||||
